Following an abbreviated submission
Lopinavir 200 mg, ritonavir 50 mg tablet (Kaletra) is accepted for use in NHS Scotland for the treatment of HIV-1 infected adults and children above the age of 2 years, in combination with other antiretroviral agents.
For patients for whom this drug combination is appropriate, it is associated with a reduced pill burden compared to an existing solid oral dose formulation containing these drugs at no increased cost.
Download detailed advice28KB (PDF)
- Medicine name:
- lopinavir 200 mg, ritonavir 50 mg tablet (Kaletra)
- SMC ID:
- Pharmaceutical company
- Abbott Laboratories Limited
- BNF chapter
- Submission type
- Date advice published
- 13 November 2006